Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...
Just five months after giving birth to our third (and final) child in 2015, my wife experienced something odd: Her smile ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Mississippi, a state known for rich culture and strong heritage, also faces some of the nation’s most glaring health disparities. Among them is the inequity in cervical cancer prevention and treatment ...
Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Genital human papillomavirus is the most common sexually transmitted infection in the United States and is thought to be ...
It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...
Cancer incidence and mortality rates are declining in Appalachia, but they are still significantly higher than among ...
Kennedy is now in control of $1.7 trillion in federal spending, vaccine recommendations, food safety and health insurance programs for roughly half the country ...
Cervical cancer begins in the epithelial cells of the cervix following an ongoing period of infection with high-risk types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results